The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Gastroenteritis Testing Market During The Forecast Period?
The gastroenteritis testing market has experienced robust expansion over the past few years. Forecasts indicate that this market is set to expand from $4.18 billion in 2025 to $4.44 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.1%. Historically, this expansion has been driven by factors such as the dependence on traditional immunoassay and culture-based techniques, the restricted access to sophisticated molecular diagnostics, a rise in the occurrence of gastrointestinal infections, enhanced diagnostic capabilities in hospitals and clinics, and the proliferation of research institutions focusing on infectious disease investigations.
The gastroenteritis testing market size is projected to experience robust expansion over the coming years, reaching $5.55 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.8%. This anticipated growth during the forecast period is attributable to progress in molecular diagnostic technologies, an increasing need for rapid point-of-care diagnostics, augmented investment in infectious disease research, the growing uptake of integrated laboratory information systems, and the broadening of gastroenteritis testing into nascent markets. Key trends expected over the forecast horizon encompass a surging requirement for swift and precise gastroenteritis diagnostic tools, the increasing implementation of molecular diagnostic testing approaches, the widening scope of viral, bacterial, and parasitic testing panels, an increase in point-of-care testing alongside hospital-based diagnostics, and a heightened emphasis on epidemiological monitoring and outbreak control.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20556&type=smp
What Key Drivers Are Fueling The Growth Of The Gastroenteritis Testing Market?
The increasing occurrence of bacterial infections is anticipated to boost the expansion of the gastroenteritis testing market in the future. The surge in bacterial infections stems from enhanced antibiotic resistance, denser populations, and more extensive global travel, all contributing to the wider dissemination of resilient bacteria. For bacterial infections, gastroenteritis testing is essential to precisely pinpoint the particular pathogen causing symptoms like diarrhea and vomiting, thereby guiding suitable treatment and curbing infection transmission. As an illustration, serious cases of bacteraemia caused by antibiotic-resistant bacteria, according to GOV.UK, a UK-based organization, rose by 9.3% in 2024 since 2023, escalating from 18,740 cases in 2023 to 20,484 cases in 2024. Consequently, the escalating prevalence of bacterial infections is propelling the development of the gastroenteritis testing market.
How Is The Gastroenteritis Testing Market Categorized Across Its Segment Groups?
The gastroenteritis testing market covered in this report is segmented –
1) By Type: Viral Gastrointestinal Infections, Bacterial Gastrointestinal Infections, Parasitic Gastrointestinal Infections
2) By Disease Strains: Bacterial Strains, Viral Strains, Parasitic Strains
3) By Testing Methods: Immunoassay Testing, Conventional Testing, Molecular Diagnostic Testing
4) By End-User: Hospitals, Clinics Or Medical Centers, Research Institutes, Diagnostic Laboratories
Subsegments:
1) By Viral Gastrointestinal Infections: Norovirus, Rotavirus, Astrovirus, Adenovirus, Sapovirus
2) By Bacterial Gastrointestinal Infections: Escherichia coli (E. coli), Salmonella, Campylobacter, Shigella, Clostridium perfringens
3) By Parasitic Gastrointestinal Infections: Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Trichinella, Strongyloides stercoralis
What Trends Are Influencing The Gastroenteritis Testing Market?
Major companies within the gastroenteritis testing market are developing innovative products, such as molecular gastrointestinal tests, to provide high sensitivity and specificity. A molecular gastrointestinal test is a diagnostic technique that utilizes molecular methods, including polymerase chain reaction (PCR), to detect and identify specific genetic material from pathogens or organisms within gastrointestinal samples. For instance, in June 2024, QIAGEN N.V., a Germany-based provider of sample and assay technologies, introduced the QIAstat-Dx Gastrointestinal Panel 2. This panel is noteworthy for its capability to rapidly and comprehensively detect up to 16 clinically relevant bacterial, viral, and parasitic pathogens responsible for most gastrointestinal infections. It leverages real-time polymerase chain reaction (PCR) technology to amplify multiple genetic targets in a single reaction, representing a significant improvement over traditional microbiological methods, which typically require 24 hours to 10 days for sample incubation.
Which Firms Are Influencing Competition In The Gastroenteritis Testing Market?
Major companies operating in the gastroenteritis testing market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Abbott Diagnostics, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Hologic Inc., Becton Dickinson and Company, bioMérieux SA, Quest Diagnostics Incorporated, DiaSorin S.p.A., Bio-Rad Laboratories Inc., Randox Laboratories Ltd., ARUP Laboratories, Meridian Bioscience Inc., MedGenome, Trinity Biotech plc, Savyon Diagnostics Ltd., Coris BioConcept, Aster Clinical Research & Diagnostic Centre Pvt. Ltd., Alimetrix Inc., Luminex Corporation
Get The Full Gastroenteritis Testing Market Report:
https://www.thebusinessresearchcompany.com/report/gastroenteritis-testing-global-market-report
Where Is The Gastroenteritis Testing Market Most Concentrated Geographically?
North America was the largest region in the gastroenteritis testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroenteritis testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Gastroenteritis Testing Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=20556&type=smp
Browse Through More Reports Similar to the Global Gastroenteritis Testing Market 2026, By The Business Research Company
Gastroesophageal Reflux Disease Gerd Market Report 2026
Immunochemistry Diagnostic Devices And Equipment Market Report 2026
Cardiac Rhythm Management Crm Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model